Literature DB >> 2138654

Effects of preventive, early, and late antifungal chemotherapy with fluconazole in different granulocytopenic models of experimental disseminated candidiasis.

T J Walsh1, S Aoki, F Mechinaud, J Bacher, J Lee, M Rubin, P A Pizzo.   

Abstract

To investigate the potential use of fluconazole for prevention and treatment of disseminated candidiasis in granulocytopenic patients, its in vivo antifungal activity was studied in three models of disseminated candidiasis in persistently granulocytopenic rabbits: acute, subacute, and chronic disseminated candidiasis. Fluconazole was compared with the combination of amphotericin B and flucytosine for preventive, early, and late treatment of disseminated candidiasis, depending on the model. Fluconazole was most effective when used for preventive or early treatment of acute and subacute disseminated candidiasis. When compared with the combination of amphotericin B plus flucytosine, fluconazole was similarly effective in early treatment of acute and subacute disseminated candidiasis. When treatment was delayed 6 days after established infection, fluconazole was less active in clearing tissues in comparison with its activity in preventive and early treatment. The combination of amphotericin B plus flucytosine, however, was significantly more active than fluconazole in treatment of chronic disseminated candidiasis in all tissues. In summary, fluconazole was most effective against disseminated candidiasis in persistently granulocytopenic rabbits when used for prevention or early treatment.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2138654     DOI: 10.1093/infdis/161.4.755

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  20 in total

Review 1.  Antifungal prophylaxis during neutropenia and immunodeficiency.

Authors:  O Lortholary; B Dupont
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

Review 2.  Antifungal agents: in vitro susceptibility testing, pharmacodynamics, and prospects for combination therapy.

Authors:  A H Groll; H Kolve
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-03-11       Impact factor: 3.267

3.  Invasive candidiasis stimulates hepatocyte and monocyte production of active transforming growth factor beta.

Authors:  J J Letterio; T Lehrnbecher; G Pollack; T J Walsh; S J Chanock
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

4.  Cilofungin (LY121019) shows nonlinear plasma pharmacokinetics and tissue penetration in rabbits.

Authors:  J W Lee; P Kelly; J Lecciones; D Coleman; R Gordee; P A Pizzo; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

5.  Antifungal Activity of Gepinacin Scaffold Glycosylphosphatidylinositol Anchor Biosynthesis Inhibitors with Improved Metabolic Stability.

Authors:  Sean D Liston; Luke Whitesell; Catherine A McLellan; Ralph Mazitschek; Vidmantas Petraitis; Ruta Petraitiene; Povilas Kavaliauskas; Thomas J Walsh; Leah E Cowen
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

6.  Safety and efficacy of multilamellar liposomal nystatin against disseminated candidiasis in persistently neutropenic rabbits.

Authors:  A H Groll; V Petraitis; R Petraitiene; A Field-Ridley; M Calendario; J Bacher; S C Piscitelli; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

7.  SCH-39304 in prevention and treatment of disseminated candidiasis in persistently granulocytopenic rabbits.

Authors:  T J Walsh; J W Lee; J Lecciones; P Kelly; J Peter; V Thomas; J Bacher; P A Pizzo
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

8.  Comparison of fluconazole and amphotericin B for treatment of experimental Candida albicans endocarditis in rabbits.

Authors:  K Chemlal; L Saint-Julien; V Joly; R Farinotti; N Seta; P Yeni; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

9.  Use of a monoclonal antibody in a dot immunobinding assay for detection of a circulating mannoprotein of Candida spp. in neutropenic patients with invasive candidiasis.

Authors:  F De Bernardis; C Girmenia; M Boccanera; D Adriani; P Martino; A Cassone
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

10.  Effects of amphotericin B and fluconazole on the extracellular and intracellular growth of Candida albicans.

Authors:  E W van Etten; N E van de Rhee; K M van Kampen; I A Bakker-Woudenberg
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.